FutureHealth Alliance announces a new partnership signed with Coba Health Care.

FutureHealth Alliance announces a new partnership signed with Coba Health Care.

Coba Health logo

AUSTIN, TX., JANUARY 14, 2019—FutureHealth Alliance, LLC. is announcing their new partnership with Coba Health, LLC. to provide access to low-cost, effective alternatives to expensive, painful surgery for knees, hips and backs, PGx and Genomic testing, treatment of diabetic wounds and chronic disease and medication management. FutureHealth Alliance and Coba Health are dedicated to helping employers reduce expense and risk associated with their employees’ healthcare while improving outcomes. FutureHealth Alliance is a strategic alliance of innovative health care providers and technologies, focused on the patient, committed to changing the face of healthcare now and for the future. Morgan Pile, Director of Business Development for Future Health Alliance, says,“We have built a turn key program from patient navigation, to data Analytics to track outcomes and ROI. Coba health gets it! When we can avoid surgeries and opioids we change employees lives and save the employer a lot of money. Its a win win for everyone!”

Coba Health LLC is a company that was created to help self-funded employers and their employees save significantly on surgical costs while maintaining an excellent level of care. Saving companies money is their mission with a growing network of providers, carefully selected based on quality. Representing over 1.2 million lives, they focus on health services that offer transparency, excellence and integrity.

“FutureHealth Alliance offers us a network of physicians offering regenerative medicine, often replacing the need of more expensive and riskier surgical procedures,” continues Doug Younker, Vice President of Sales for Coba. “With comparable outcomes, less expense, less pain and faster recovery times it’s a tremendous alternative for many of the employees we represent.” The addition of PGx testing also offers the benefit of finding the most effective medications for each patient. “In the face of the US opioid epidemic, using less painful procedures and targeting the most effective prescriptions is a must,” continues Doug, “this importance is something I personally witnessed as an HR director and a big benefit to all of our employers, employees and their families.”

Lucia Fields, RN, BSN, Diplomate, ABAAHP Fellow, Stem Cells ABAARM, is the founder and managing director for FutureHealth Alliance. “It’s a huge selling point when we can demonstrate such significant savings for an employer on orthopedic surgical costs by implementing a regenerative medicine component in their plan, states Lucia. “Savings may gain their initial interest but the feedback from an employee who is experiencing substantially less pain within weeks of a procedure, and no longer on daily pain medication is what makes them a believer and passionate advocate.”

Dr. David Harshfield, active board member of the American Association of Orthopedic Medicine, integral to the passage of the Arkansas Emerging Therapies Act of 2017 and chairman of the IRB board at the International Cellular Medicine Society (ICMS) agrees. “The financial benefits of using regeneratiave therapies are inarguable however the bigger benefit long-term is the reintroduction of the fundamental human relationship between physician and patient.” Harshfield agrees, “health care requires a human face, in which the time-honored art of healing guides physicians in their approach to patient and family centered care and a more judicious use of medical technology.” 